AN2 Therapeutics, Inc. (ANTX) Tops Q2 EPS by 10c

AN2 Therapeutics, Inc. (NASDAQ: ANTX) reported Q2 EPS of ($0.21), $0.10 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on AN2 Therapeutics, Inc. (ANTX) click here.

You May Also Be Interested In

• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Star Equity Holdings (STRR) Misses Q2 EPS by 8c